We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gastric Bypass and Sleeve Gastrectomy Equally Effective

By HospiMedica International staff writers
Posted on 30 Jan 2018
A new study concludes that in the morbidly obese, there is no significant difference in excess body mass index (BMI) loss between sleeve gastrectomy and Roux-en-Y gastric bypass (RYGBP).

Researchers at University Hospital Basel (Switzerland), St. More...
Claraspital (Basel, Switzerland), and other institutions conducted a randomized, two-group trial between January 2007 and November 2011 involving 217 patients (average age 45.5 years, 72% women) who randomly assigned to sleeve gastrectomy (107 patients) or RYGBP (110 patients) in order to compare the two procedures in terms of weight loss, changes in comorbidities, increase in quality of life, and adverse events.

The results revealed that in terms of weight loss, both laparoscopic procedures led to similar results at five-year follow-up. Patients lost 68% of their excess weight after a gastric bypass, and 61% after a sleeve gastrectomy, with BMI falling from 44 to 32 for both. Patients with existing gastric acid reflux benefited more from RYGBP, with symptoms eliminated in 60%, compared to just 25% following sleeve gastrectomy. Associated diseases such as hypertension, diabetes, back/joint pain and depression were also improved, as well as general quality of life. The study was published on January 16, 2018, in JAMA.

“We have always paid attention to gastroesophageal reflux (GERD) when advising patients as to which operation they should get, but 31.8% of the people who received the sleeve procedure saw their acid reflux symptoms increase, compared to just 6.3% of those getting the older bypass procedure,” said lead author Ralph Peterli, MD, of St Claraspital. “As a result of the study, we tell them that every third patient not suffering from GERD before surgery may end up experiencing some degree of it in the long run.”

Bariatric surgery is achieved by reducing the size of the stomach with an implanted medical device such as a gastric band (GB), through removal of a portion of the stomach via a vertical sleeve gastrectomy or through a biliopancreatic diversion with duodenal switch (BPD-DS), or by resecting and re-routing the small intestines to a small stomach pouch (RYGBP). In the United States there is a much greater increase in GB than RYGBP, probably due to the preconception that GB is a "simple and safer" procedure.

Related Links:
University Hospital Basel
St. Claraspital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.